Get started
Author

Charlotte Hiu-Yan Chung

Observed names: Charlotte Chung, Charlotte H. Y. Chung, Charlotte H.Y. Chung, Charlotte H.‐Y. Chung, Charlotte Hiu-Yan Chung
Observed institutions: Chinese University of Hong Kong, Oklahoma Medical Research Foundation, Voyager Therapeutics (United States), University of Oklahoma Health Sciences Center, University of Pennsylvania, University of Oklahoma
ORCID: 0000-0003-4838-1343
Observed ORCID: 0000-0003-4838-1343
OpenAlex ID: A5057802982
α-Synuclein Immunotherapy Blocks Uptake and Templated Propagation of Misfolded α-Synuclein and Neurodegeneration
2014 · Hien T. Tran, Charlotte Hiu-Yan Chung, et al. · Cell Reports · 335
Rapid evolution of blood-brain-barrier-penetrating AAV capsids by RNA-driven biopanning
2020 · Mathieu Nonnenmacher, Wei Wang, et al. · Molecular Therapy — Methods & Clinical Development · 171
PDF
Apolipoprotein Receptor 2 and X11α/β Mediate Apolipoprotein E-Induced Endocytosis of Amyloid-β Precursor Protein and β-Secretase, Leading to Amyloid-β Production
2007 · Xiangyuan He, Kathleen Cooley, et al. · Journal of Neuroscience · 110
PDF
Highly conserved brain vascular receptor ALPL mediates transport of engineered AAV vectors across the blood-brain barrier
2025 · Tyler C. Moyer, Brett A. Hoffman, et al. · Molecular Therapy · 64
PDF
Identification of Lanthionine Synthase C-like Protein-1 as a Prominent Glutathione Binding Protein Expressed in the Mammalian Central Nervous System
2007 · Charlotte H. Y. Chung, Biji T. Kurien, et al. · Biochemistry · 49
NPT088 reduces both amyloid‐β and tau pathologies in transgenic mice
2016 · Jonathan M. Levenson, Sally Schroeter, et al. · Alzheimer s & Dementia Translational Research & Clinical Interventions · 48
PDF
Characterization of novel conformation-selective α-synuclein antibodies as potential immunotherapeutic agents for Parkinson's disease
2019 · Michael X. Henderson, Dustin J. Covell, et al. · Neurobiology of Disease · 46
PDF
Unbiased Proteomics of Early Lewy Body Formation Model Implicates Active Microtubule Affinity-Regulating Kinases (MARKs) in Synucleinopathies
2017 · Michael X. Henderson, Charlotte Hiu-Yan Chung, et al. · Journal of Neuroscience · 39
PDF
The Postnatal Development of the Cerebellum— A fMRI and Silver Study
2005 · Marong Fang, Lihong Zhang, et al. · Cellular and Molecular Neurobiology · 7
Expression and processing of fluorescent fusion proteins of amyloid precursor protein (APP)
2013 · Kathleen Coughlan, Xiangping Huang, et al. · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · 4
PDF
GAIM fusions are therapeutic candidates for peripheral amyloidosis
2019 · Ming Proschitsky, Jonathan Levenson, et al. · Amyloid · 3
Identification and characterization of novel anti‐tau antibodies that inhibit tau‐seed mediated pathology in a P301S tauopathy mouse model Alzheimer’s Disease and tauopathies
2022 · Wencheng Liu, Vinodh Kurella, et al. · Alzheimer s & Dementia
Efficacy evaluation of a novel vectorized anti‐tau antibody, targeting a C‐terminal phospho‐tau epitope, using systemic dosing of a blood brain barrier penetrant AAV capsid in mouse models of tauopathies.
2022 · Wencheng Liu, Maneesha Paranjpe, et al. · Alzheimer s & Dementia
Efficacy of a vectorized anti‐tau antibody using systemic dosing of a blood brain barrier penetrant AAV capsid in mouse models of tauopathies
2021 · Wencheng Liu, Jerrah Holth, et al. · Alzheimer s & Dementia
[p3–188]: Mutagenesis of the General Amyloid Interaction Motif (gaim) Reveals a Structure‐activity Relationship for Misfolded Beta‐amyloid and Tau Aggregates
2017 · Rajaraman Krishnan, Eva Asp, et al. · Alzheimer s & Dementia
Works count: 15
Citation count: 876
H-index: 8
I10-index: 8
Year
Topic
Type